Mr. Greve (born 1960), works as a strategic advisor at Cipriano AS. Mr. Greve has previously worked as partner at Wikborg Rein & Co for 15 years and as partner of Arctic Securities ASA. Mr. Greve has held and holds various positions in Norwegian listed and unlisted companies. He holds a degree in law (cand.jur) from the University of Oslo. He is a Norwegian citizen and resides in Oslo, Norway.

Board member

Ms. Hammergren (born 1967) currently holds the position as Executive Vice President at BI Norwegian Business School. She has previously held positions as Marketing Director at Lilleborg, Director Orkla Brands Marketing and Sales, Assistant Director at Schibsted and European Brand Manager at Unilever. She has been a member of the board at Orkla Finans Kapitalforvaltning ASA, Adresseavisen ASA and Stenersen Forlag AS. Ms. Hammergren holds a Master of Science degree in Business from The Norwegian School of Economics (NHH). She is a Norwegian citizen and resides in Oslo, Norway.

Board member

Ms. Wilhelmsen (born 1962) is Co-Owner and Chief Financial Officer of WAK Family Office - Watrium. She is a member of the board at Swedbank Asset Management AS and a number of the Wilhelmsen family's' investment – and property companies. Ms. Wilhelmsen holds a degree in economics from the University of Lund, Sweden. Watrium AS today holds 12.09% of the shares in Weifa ASA. She is a Norwegian citizen and resides in Oslo, Norway.

Board member

Mr. Settevik (born 1960) is an independent investor operating a family investment vehicle, Mutus AS. Before starting as an independent investor he worked as CEO of Stokke AS, CEO of Pronova BioPharma ASA, Vice President Northern Europe Covidien (Tyco Healthcare), Vice President EMEA Marketing and R&D Covidien (Tyco Healthcare), Managing Director UK& Norden Covidien (Tyco Healthcare) and General Manager Norden, United States Surgical Corporation. He is a board member at Made for Movement Group AS. Mr. Settevik holds a Bachelor of Social Science and Business Administration from Copenhagen Business School (CBS). He is a Norwegian citizen and resides in Oslo, Norway.

Board member

Mr Jørgensen is currently portfolio manager of Holta Invest AS and managing director of Holta Life Sciences AS, one of the largest shareholders in Weifa ASA. He has 15 years of experience as healthcare analyst and portfolio manager within the life sciences sector. Mr Jørgensen is currently a board member of Gentian Technology AS and PreTect AS, which are both operating in the diagnostic market, and has previously been a board member of Strongbridge BioPharma, a biotech company developing treatments for orphan, endocrine diseases. He holds a Bsc degree in economics and has also completed 3 years of medicine studies at the University of Oslo.